COVID-19 vaccine: Govt signs fresh deal with Serum Institute for 20 million Covishield doses1 min read . Updated: 09 Mar 2021, 07:22 PM IST
- The central government in January ordered 11 million doses of the Oxford-AstraZeneca COVID-19 vaccine from Serum Institute of India
The Centre has inked a fresh deal with Serum Institute of India for 20 million doses of its COVID-19 vaccine, sources told Mint. The order was signed last week, sources confirmed. Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with British-Swedish drugmaker to produce 1 billion doses of its COVID-19 vaccine. The local version of Oxford-AstraZeneca COVID-19 vaccine will be known as Covishield.
Select your Category